Kara Magane
Profiles

Kara Magane, MS

Senior Director of Research Operations, Health Law, Policy & Management - Boston University School of Public Health

Biography

Kara Magane, MS, is Senior Director of Research Operations at the Boston University School of Public Health, where she manages a broad research portfolio spanning multiple departments on the BU Medical Campus. She supports the design, coordination, and implementation of large, complex, and multi-site studies, with a focus on building and sustaining research infrastructure and facilitating collaboration among investigators, teams, and external partners. Her work emphasizes operational efficiency, regulatory compliance, and research integrity.

She joined BU in 2019 following research roles at Boston Children’s Hospital and the University of Pennsylvania, where she contributed to studies focused on substance use and colorectal cancer screening. She holds a Master of Science in Health Promotion and a Bachelor of Arts in Sociology, magna cum laude, from the University of Delaware.

Her research contributions have been published in journals including JAMA Internal Medicine, Addiction Science & Clinical Practice, and Pediatrics, with a focus on substance use, HIV, and chronic disease.

Websites

Publications

  • Published on 9/4/2025

    Weinstein ZM, Magane KM, Lodi S, Doeleman D, Ventura AS, Bazzi AR, Davoust M, Shea MG, Chen CA, Cheng A, Theisen J, Blakemore S, Saitz R. Associations between COVID impact domains and time to buprenorphine treatment disengagement. Am J Drug Alcohol Abuse. 2025 Sep 04; 1-10. PMID: 40906491.

    Read At: PubMed
  • Published on 8/28/2025

    Theisen J, Weinstein ZM, Davoust M, Ventura AS, Magane KM, Cheng A, Blakemore S, Blodgett J, Fielman S, Saitz R, Bazzi AR. Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment. Subst Use Addctn J. 2025 Aug 28; 29767342251360850. PMID: 40876939.

    Read At: PubMed
  • Published on 7/23/2025

    Taghian NR, Palfai TP, Winter MR, Kim TW, Magane KM, Saitz R, Stein MD. Pain and alcohol consumption among people living with HIV: examining the moderating roles of depression and social support. Alcohol. 2025 Nov; 128:13-20. PMID: 40712846.

    Read At: PubMed
  • Published on 6/1/2025

    Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645. PMID: 40257810.

    Read At: PubMed
  • Published on 3/4/2025

    Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A, Fielman S, Magane KM, Theisen J, Saitz R, Ventura AS, Weinstein ZM. Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study. Addict Sci Clin Pract. 2025 Mar 04; 20(1):21. PMID: 40033433.

    Read At: PubMed
  • Published on 2/5/2025

    Magane KM, Saitz R, Fielman S, LaRochelle MR, Shanahan CW, Pace CA, LaValley M, Penington K, Karzhevsky S, Hurstak E. Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial. Addict Sci Clin Pract. 2025 Feb 05; 20(1):9. PMID: 39910606.

    Read At: PubMed
  • Published on 12/2/2024

    Bart G, Barth KS, Baukol P, Enns E, Ghitza UE, Harris J, Jelstrom E, Liebschutz JM, Magane KM, Voronca D, Weinstein ZM, Korthuis PT. Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versus treatment as usual on post-hospital treatment engagement for hospitalized patients with opioid use disorder. Addict Sci Clin Pract. 2024 Dec 02; 19(1):91. PMID: 39623502.

    Read At: PubMed
  • Published on 10/22/2024

    Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470. PMID: 39461121.

    Read At: PubMed
  • Published on 9/27/2024

    Shangani S, Winter MR, Shea M, Kim TW, So-Armah K, Magane KM, Bellamy SL, Saitz R, Stein MD. Social Vulnerability and Mental Health Among People with HIV and Substance Use: The Role of Race. AIDS Behav. 2024 Dec; 28(12):4094-4105. PMID: 39327395.

    Read At: PubMed
  • Published on 9/24/2024

    Palfai TP, Winter MR, Magane KM, Heeren TC, Bernier LB, Murray GE, Saitz R, Kim TW, Stein MD. Pain and unhealthy alcohol use among people living with HIV: A prospective cohort study. Alcohol Clin Exp Res (Hoboken). 2024 Nov; 48(11):2089-2098. PMID: 39317678.

    Read At: PubMed

News & In the Media